Product:
Neumonil Multiple Relief

Combined Presentation:
Box of two Injectable Neumonil solution ampoules + four Neumonil Forte NF tablets

Formula
Neumonil Forte NF: Each tablet contains:
Acetaminophen 500mg
Phenylephrine hydrochloride 5mg
Chlorpheniramine Maleate 2 mg
Dextromethorphan HBr 10 mg
Excipients q.s.

Injectable Neumonil Solution: Each ampoule (1mL) contains:
Guaiacolate 50mg
Eucalyptus 120mg
Vehicle: q.s.

Indications for use: Neumonil Forte NF tablets contain medicines and proper doses to relief of the main discomforts of colds and flu, they are especially effective during the first flu symptoms. Acetaminophen fighs pain and fever, Phenylephrine decongests respiratory tract, Chlorpheniramine reduces secretions, itchy ears, eyes and/or nose and dextromethorphan acts as a cough suppressant.

Neumonil injection is effective against the signs and symptoms of catarrhal conditions such as cough, runny nose and conjunctival inflammation.

Dosage and Instrucions:
Adults and children over 12 years old:
Ampoules: administer 1-2 Injectable Neumonil ampoules every 24 hours for 3 days intramuscularly.
Tablets: To complete relief of symptoms of flu and cough take 1 or 2 tablets of Neumonil Forte NF every 4 to 6 hours not to exceed 8 tablets in 24 hours.

Cautions and Warnings: Neumonil Forte NF: Consult before taking this medication if you are under medical treatment and in the following cases: hypertension, heart problems, diabetes or prostate enlargement, persistent or chronic cough, asthma or emphysema or if cough is accompanied by excessive phlegm and in elderly patients. Do not consume alcohol or other sedative products. This product may cause drowsiness, if this happens, do not drive or operate machinery. It can also cause nervousness, palpitations, insomnia and dry mouth. Usually these reactions disappear by reducing the dose, if they persist discontinue the treatment. At recommended doses, unwanted side effects are not observed. Use with caution in patients with renal or hepatic insufficiency. If symptoms persist, worsen or other symptoms appear, consult your doctor. Do not exceed recommended dose. Do not administer more than 5 consecutive days in children, or more than 10 days in adults, if pain persists, or for more than 3 days if fever persists.

Injectable Neumonil: Do not administrate to patients with epilepsy or convulsive crisis history, or tuberculosis.

If you have any doubt about the use of this product, ask your doctor or contact our department of Pharmacovigilance by clicking here.